106 related articles for article (PubMed ID: 11365725)
1. A further point about statins...
Gilden D
GMHC Treat Issues; 1998 Jun; 12(6):8. PubMed ID: 11365725
[TBL] [Abstract][Full Text] [Related]
2. Potential interactions between cholesterol lowering drugs and protease inhibitors.
Notes Undergr; 1998; (No 37):8. PubMed ID: 11365822
[TBL] [Abstract][Full Text] [Related]
3. Dietary consideration and protease inhibitors.
Lichtenstein BS
STEP Perspect; 1996; 8(3):11-4. PubMed ID: 11364264
[TBL] [Abstract][Full Text] [Related]
4. Party at your own risk.
Cox S
Posit Aware; 1997; 8(3):32-7. PubMed ID: 11364423
[TBL] [Abstract][Full Text] [Related]
5. Double jeopardy: the hazards of drug-drug interactions.
Flexner C
Res Initiat Treat Action; 1998 Dec; 4(7):3-8. PubMed ID: 11366084
[TBL] [Abstract][Full Text] [Related]
6. [Metabolic interactions with statins].
Molden E; Asberg A
Tidsskr Nor Laegeforen; 2001 Jan; 121(2):189-93. PubMed ID: 11475198
[TBL] [Abstract][Full Text] [Related]
7. Ritonavir-fluticasone interaction causing Cushing syndrome in HIV-infected children and adolescents.
Arrington-Sanders R; Hutton N; Siberry GK
Pediatr Infect Dis J; 2006 Nov; 25(11):1044-8. PubMed ID: 17072128
[TBL] [Abstract][Full Text] [Related]
8. Depression & HIV: assessment and treatment.
Elliott A
STEP Perspect; 1997; 9(1):1-5. PubMed ID: 11364269
[TBL] [Abstract][Full Text] [Related]
9. Drug interactions. Kaletra and ezetimibe.
TreatmentUpdate; 2006; 18(3):8. PubMed ID: 17209242
[No Abstract] [Full Text] [Related]
10. Lipid-lowering efficacy and safety after switching to atazanavir-ritonavir-based highly active antiretroviral therapy in patients with human immunodeficiency virus.
Nguyen ST; Eaton SA; Bain AM; Rahman AP; Payne KD; Bedimo R; Herrington JD; Maclayton DO; Rodriguez-Barradas MC; Busti AJ
Pharmacotherapy; 2008 Mar; 28(3):323-30. PubMed ID: 18294112
[TBL] [Abstract][Full Text] [Related]
11. Disorders of lipid metabolism in patients with HIV disease treated with antiretroviral agents: frequency, relationship with administered drugs, and role of hypolipidaemic therapy with bezafibrate.
Manfredi R; Chiodo F
J Infect; 2001 Apr; 42(3):181-8. PubMed ID: 11545549
[TBL] [Abstract][Full Text] [Related]
12. Lipid lowering therapy with fluvastatin and pravastatin in patients with HIV infection and antiretroviral therapy: comparison of efficacy and interaction with indinavir.
Benesic A; Zilly M; Kluge F; Weissbrich B; Winzer R; Klinker H; Langmann P
Infection; 2004 Aug; 32(4):229-33. PubMed ID: 15293079
[TBL] [Abstract][Full Text] [Related]
13. Lipid lowering effects of statins and fibrates in the management of HIV dyslipidemias associated with antiretroviral therapy in HIV clinical practice.
Visnegarwala F; Maldonado M; Sajja P; Minihan JL; Rodriguez-Barradas MC; Ong O; Lahart CJ; Hasan MQ; Balasubramanyam A; White AC
J Infect; 2004 Nov; 49(4):283-90. PubMed ID: 15474625
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol reduction, statins and the cytochrome P-450 system.
Cockcroft JR; Wilkinson IB
Eur Heart J; 2000 Sep; 21(18):1555-6. PubMed ID: 10973770
[No Abstract] [Full Text] [Related]
15. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
16. HIV protease inhibitors and dyslipidemia.
Clotet B; Negredo E
AIDS Rev; 2003; 5(1):19-24. PubMed ID: 12875104
[TBL] [Abstract][Full Text] [Related]
17. Drugs and the liver.
Treat Rev; 1998; (No 28):4-6. PubMed ID: 11365425
[TBL] [Abstract][Full Text] [Related]
18. [Concerning: Devuyst G, Bogousslavsky I. Cholesterol and risk of cerebrovascular accidant: a role for statins?].
Koch HJ; Hau P; Steinbrecher A
Schweiz Med Wochenschr; 2000 Dec; 130(48):1863-4. PubMed ID: 11132532
[No Abstract] [Full Text] [Related]
19. Management of dyslipidaemia in HIV-infected patients receiving antiretroviral therapy.
MartÃnez E; Tuset M; Milinkovic A; Miró JM; Gatell JM
Antivir Ther; 2004 Oct; 9(5):649-63. PubMed ID: 15535403
[TBL] [Abstract][Full Text] [Related]
20. Interaction between lopinavir/ritonavir and warfarin.
Hughes CA; Freitas A; Miedzinski LJ
CMAJ; 2007 Aug; 177(4):357-9. PubMed ID: 17698824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
